160 related articles for article (PubMed ID: 33544438)
21. Evaluation of Polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma.
Kadletz L; Bigenzahn J; Thurnher D; Stanisz I; Erovic BM; Schneider S; Schmid R; Seemann R; Birner P; Heiduschka G
Head Neck; 2016 Apr; 38 Suppl 1():E1918-25. PubMed ID: 26713885
[TBL] [Abstract][Full Text] [Related]
22. PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma.
Barkdull S; Brownell I
Cancer Biol Ther; 2017 Dec; 18(12):937-939. PubMed ID: 29172995
[TBL] [Abstract][Full Text] [Related]
23. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
Paulson KG; Bhatia S
J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
[TBL] [Abstract][Full Text] [Related]
24. Peptide receptor radionuclide therapy of Merkel cell carcinoma using (177)lutetium-labeled somatostatin analogs in combination with radiosensitizing chemotherapy: a potential novel treatment based on molecular pathology.
Salavati A; Prasad V; Schneider CP; Herbst R; Baum RP
Ann Nucl Med; 2012 May; 26(4):365-9. PubMed ID: 22361935
[TBL] [Abstract][Full Text] [Related]
25. Merkel Cell Carcinoma: Current Issues Regarding Diagnosis, Management, and Emerging Treatment Strategies.
Brummer GC; Bowen AR; Bowen GM
Am J Clin Dermatol; 2016 Feb; 17(1):49-62. PubMed ID: 26596990
[TBL] [Abstract][Full Text] [Related]
26. Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions.
Gallo M; Guarnotta V; De Cicco F; Rubino M; Faggiano A; Colao A;
J Cancer Res Clin Oncol; 2019 Feb; 145(2):429-443. PubMed ID: 30617553
[TBL] [Abstract][Full Text] [Related]
27. Adcitmer
Esnault C; Leblond V; Martin C; Desgranges A; Baltus CB; Aubrey N; Lakhrif Z; Lajoie L; Lantier L; Clémenceau B; Sarma B; Schrama J; Houben R; Schrama D; Hesbacher S; Gouilleux-Gruart V; Feng Y; Dimitrov D; Guyétant S; Berthon P; Viaud-Massuard MC; Samimi M; Touzé A; Kervarrec T
Br J Dermatol; 2022 Feb; 186(2):295-306. PubMed ID: 34582565
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin-based chemotherapy for merkel cell carcinoma of the skin.
Pectasides D; Pectasides M; Psyrri A; Koumarianou A; Xiros N; Pectasides E; Gaglia A; Lianos E; Papaxoinis G; Lampadiari V; Economopoulos T
Cancer Invest; 2006 Dec; 24(8):780-5. PubMed ID: 17162559
[TBL] [Abstract][Full Text] [Related]
29. Merkel cell carcinoma update: the case for two tumours.
Nirenberg A; Steinman H; Dixon J; Dixon A
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1425-1431. PubMed ID: 31855292
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma (MCC): A multicenter experience.
van Veenendaal LM; Madu MF; Tesselaar MET; Verhoef C; Grünhagen DJ; van Akkooi ACJ
Eur J Surg Oncol; 2017 Nov; 43(11):2157-2162. PubMed ID: 28802661
[TBL] [Abstract][Full Text] [Related]
31. Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 Patients.
Tarabadkar ES; Thomas H; Blom A; Parvathaneni U; Olencki T; Nghiem P; Bhatia S
Am J Case Rep; 2018 Apr; 19():505-511. PubMed ID: 29706615
[TBL] [Abstract][Full Text] [Related]
32. Advanced Merkel cell carcinoma-A focus on medical drug therapy.
Wollina U; Koch A; Cardoso JC
Dermatol Ther; 2020 Jul; 33(4):e13675. PubMed ID: 32447821
[TBL] [Abstract][Full Text] [Related]
33. [Update in treatment for Merkel Cell Carcinoma and clinical practice guide].
Tétu P; Baroudjian B; Madelaine I; Delyon J; Lebbé C
Bull Cancer; 2019 Jan; 106(1):64-72. PubMed ID: 30579571
[TBL] [Abstract][Full Text] [Related]
34. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs.
Schadendorf D; Lebbé C; Zur Hausen A; Avril MF; Hariharan S; Bharmal M; Becker JC
Eur J Cancer; 2017 Jan; 71():53-69. PubMed ID: 27984768
[TBL] [Abstract][Full Text] [Related]
35. Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.
Amaral T; Leiter U; Garbe C
Rev Endocr Metab Disord; 2017 Dec; 18(4):517-532. PubMed ID: 28916903
[TBL] [Abstract][Full Text] [Related]
36. An Unusual Presentation of Merkel Cell Carcinoma in a HIV Patient: A Case Report and Literature Review.
Ramachandran P; Erdinc B; Gotlieb V
J Investig Med High Impact Case Rep; 2019; 7():2324709619836695. PubMed ID: 30938171
[TBL] [Abstract][Full Text] [Related]
37. Molecular characteristics and potential therapeutic targets in Merkel cell carcinoma.
Mauzo SH; Ferrarotto R; Bell D; Torres-Cabala CA; Tetzlaff MT; Prieto VG; Aung PP
J Clin Pathol; 2016 May; 69(5):382-90. PubMed ID: 26818033
[TBL] [Abstract][Full Text] [Related]
38. ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth.
Kleffel S; Lee N; Lezcano C; Wilson BJ; Sobolewski K; Saab KR; Mueller H; Zhan Q; Posch C; Elco CP; DoRosario A; Garcia SS; Thakuria M; Wang YE; Wang LC; Murphy GF; Frank MH; Schatton T
J Invest Dermatol; 2016 Apr; 136(4):838-846. PubMed ID: 26827764
[TBL] [Abstract][Full Text] [Related]
39. Complete response with neoadjuvant avelumab in Merkel cell carcinoma - A case report.
Abdallah N; Nagasaka M; Chowdhury T; Raval K; Hotaling J; Sukari A
Oral Oncol; 2019 Dec; 99():104350. PubMed ID: 31277904
[TBL] [Abstract][Full Text] [Related]
40. Merkel cell carcinoma: case report and literature review, from a remote region of France.
Zucchi S
Rural Remote Health; 2009; 9(1):1072. PubMed ID: 19206996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
